BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 17111334)

  • 21. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.
    Luu TD; Gaur P; Force SD; Staley CA; Mansour KA; Miller JI; Miller DL
    Ann Thorac Surg; 2008 Apr; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Endoscopic photodynamic diagnosis and therapy with the laser in esophageal, stomach and lung cancer].
    Kato H; Konaka C; Kawate N; Nishimiya K; Saito M; Kinoshita K; Sakai H; Okitsu H; Kawaguchi M; Aizawa K
    Internist (Berl); 1985 Nov; 26(11):675-87. PubMed ID: 3000973
    [No Abstract]   [Full Text] [Related]  

  • 23. Does previous fundoplication alter the surgical approach to esophageal adenocarcinoma?
    Casson AG; Madani K; Mann S; Zhao R; Reeder B; Lim HJ
    Eur J Cardiothorac Surg; 2008 Nov; 34(5):1097-101; discussion 1101-2. PubMed ID: 18774726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie.
    Al-Batran SE; Hartmann JT; Probst S; Schmalenberg H; Hollerbach S; Hofheinz R; Rethwisch V; Seipelt G; Homann N; Wilhelm G; Schuch G; Stoehlmacher J; Derigs HG; Hegewisch-Becker S; Grossmann J; Pauligk C; Atmaca A; Bokemeyer C; Knuth A; Jäger E;
    J Clin Oncol; 2008 Mar; 26(9):1435-42. PubMed ID: 18349393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group.
    Van Cutsem E; Van de Velde C; Roth A; Lordick F; Köhne CH; Cascinu S; Aapro M;
    Eur J Cancer; 2008 Jan; 44(2):182-94. PubMed ID: 18093827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subsite-specific risk factors for esophageal and gastric adenocarcinoma.
    Crane SJ; Locke GR; Harmsen WS; Diehl NN; Zinsmeister AR; Melton LJ; Romero Y; Talley NJ
    Am J Gastroenterol; 2007 Aug; 102(8):1596-602. PubMed ID: 17459024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Synchronous esophageal and stomach neoplasm: importance of diagnosis and treatment].
    Domene CE; Volpe P; Pinotti A; Santo MA; Onari P; Cecconello I; Pinotti HW
    Rev Hosp Clin Fac Med Sao Paulo; 1998; 53(5):263-6. PubMed ID: 10436638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric adenocarcinomas in Los Angeles County.
    Duan L; Wu AH; Sullivan-Halley J; Bernstein L
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):126-34. PubMed ID: 18187391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delays in diagnosing oesophagogastric cancer. Small study found that four fifths of delay was due to patients.
    Wayman J; Raimes S; Griffin SM; Hayes N
    BMJ; 1997 Aug; 315(7105):428. PubMed ID: 9277617
    [No Abstract]   [Full Text] [Related]  

  • 30. Gastric adenocarcinoma with distant metastasis: is gastrectomy necessary?
    Sarela AI; Yelluri S;
    Arch Surg; 2007 Feb; 142(2):143-9; discussion 149. PubMed ID: 17309965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extreme aggressiveness and lethality of gastric adenocarcinoma in the very young.
    Smith BR; Stabile BE
    Arch Surg; 2009 Jun; 144(6):506-10. PubMed ID: 19528381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome after esophagectomy for cancer of the esophagus and GEJ in patients aged over 75 years.
    Internullo E; Moons J; Nafteux P; Coosemans W; Decker G; De Leyn P; Van Raemdonck D; Lerut T
    Eur J Cardiothorac Surg; 2008 Jun; 33(6):1096-104. PubMed ID: 18407509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands.
    de Vries AC; van Grieken NC; Looman CW; Casparie MK; de Vries E; Meijer GA; Kuipers EJ
    Gastroenterology; 2008 Apr; 134(4):945-52. PubMed ID: 18395075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does neoadjuvant treatment for gastric cancer patients with positive peritoneal cytology at staging laparoscopy improve survival?
    Badgwell B; Cormier JN; Krishnan S; Yao J; Staerkel GA; Lupo PJ; Pisters PW; Feig B; Mansfield P
    Ann Surg Oncol; 2008 Oct; 15(10):2684-91. PubMed ID: 18649106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective randomised clinical trial of providing patients with audiotape recordings of their oesophagogastric cancer consultations.
    Stephens MR; Gaskell AL; Gent C; Pellard S; Day-Thompson R; Blackshaw GR; Lewis WG
    Patient Educ Couns; 2008 Aug; 72(2):218-22. PubMed ID: 18513915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current aspects of gastric cancer in Senegal. Epidemiological and clinical study of 220 cases (1984-1991)].
    Niang A; Mbengue M; Diouf ML; Diouf B; Ka MM; Pouye A; Diallo S; Ndiaye MF; Bao O
    Dakar Med; 1996; 41(2):99-103. PubMed ID: 9827102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved quality of life outcomes after laparoscopy-assisted distal gastrectomy for early gastric cancer: results of a prospective randomized clinical trial.
    Kim YW; Baik YH; Yun YH; Nam BH; Kim DH; Choi IJ; Bae JM
    Ann Surg; 2008 Nov; 248(5):721-7. PubMed ID: 18948798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma.
    Rizk NP; Venkatraman E; Bains MS; Park B; Flores R; Tang L; Ilson DH; Minsky BD; Rusch VW;
    J Clin Oncol; 2007 Feb; 25(5):507-12. PubMed ID: 17290058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical analysis of 108 cases with adenocarcinoma Barretts's esophagus].
    Han JQ; Liu Q; Liang RX; Qu FS; Yan TX; Sun YH; Li XQ
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):470-3. PubMed ID: 17974287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
    Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
    Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.